The concurrent expression of p27(kip1) and cyclin D1 in epithelial ovarian tumors

Gynecologic Oncology

Volumn 73, Issue 2, 1999, Pages 202-209

  Sui, Li ^a   Tokuda, Masaaki ^a   Ohno, Masayuki ^a   Hatase, Osamu ^a   Hando, Tamotsu ^a  

^a KAGAWA UNIVERSITY   (Japan)

Author keywords

cdk2; Cyclin D1; Cyclin E; Ovarian tumors; p27(kip1)

Indexed keywords

CYCLIN D1; CYCLIN DEPENDENT KINASE; CYCLIN E; PROTEIN P27;

ARTICLE; CANCER GRADING; CLINICAL ARTICLE; EPITHELIUM TUMOR; FEMALE; GENE EXPRESSION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALIGNANT TRANSFORMATION; OVARY TUMOR; PRIORITY JOURNAL;

EID: 0032931805     PISSN: 00908258     EISSN: None     Source Type: Journal    
DOI: 10.1006/gyno.1999.5373     Document Type: Article

References (36)

1. 1 cyclins. Cell 73:1059-1065, 1993
2. Sherr CJ: G1 phase progression: cycling on cue. Cell 79:551-555, 1994
3. 1-S phase protein kinase. Science 257:1958-1961, 1992
4. 1 phase of the human cell-cycle. Science 257:1689-1694, 1992
5. Hunter T, Pines J: Cyclins and cancer: cyclin D and cdk inhibitors come of age. Cell 79:573-582, 1994
6. kip1, a cyclin-dependent kinase inhibitor and a potential mediator of extracellular antimitogenic signals. Cell 78:59-66, 1994
7. Toyoshima, Hunter T: p27, a novel inhibitor of G1 cyclin/cdk protein kinase activity, is related to p21. Cell 78:67-74, 1994
8. sdi1/ClP1/WAF1 EMBO J 14:555-563, 1995
9. Kawamata N, Morosetti R, Miller CW, Park D, Spirin KS, Nakamaki T, Takeuchi S, Hatta Y, Simpson J, Wilczynski S, Lee YY, Bartram CR, Koeffler HP: Molecular analysis of the cyclin-dependent kinase inhibitor gene p27/kip1 in human malignancies. Cancer Res 55:2266-2269, 1995
10. Rosner B: Fundamentals of biostatistics third edition. Boston, PWS-KENT Publishing Company, 1990, pp 357-458
11. kip1) of cyclin-dependent kinase 4 activation. Cell 79:487-496, 1994
12. kip1 cyclin-dependent kinase inhibitor prevented by rapamycin. Nature 372:570-573, 1994
13. kip1 and degree of malignancy in human breast and colorectal cancers. Proc Natl Acad Sci USA 94:6380-6385, 1997
14. kip1 display increased body size, multiple organ hyperplasia, retinal dysplasia, and pituitary tumors. Cell 85:707-720, 1996
15. kip1-deficient mice. Cell 85:733-744, 1996
16. kip1. Cell 85:721-732, 1996
17. Lloyd RV, Jin L, Qian X, Kulig E: Aberrant p27kip1 expression in endocrine and other tumors. Am J Pathol 150:401-407, 1997
18. kip1 protein: prognostic implications in primary breast cancer. Nature Med 3:227-230, 1997
19. Loda M, Cukor B, Tam SW, Lavin P, Fiorentino M, Draetta GF, Jessup JM, Pagano M: Increased proteasome-dependent degradation of the cyclin-dependent kinase inhibitor p27 in aggressive colorectal carcinomas. Nature Med 3:231-234, 1997
20. Pagano M, Tam SW, Theodoras AM, Beer-Romero P, Sal GD, Chau V, Yew PR, Draetta GF, Rolfe M: Role of the ubiquitin-proteasome pathway in regulating abundance of the cyclin-dependent kinase inhibitor p27. Science 269:682-685, 1995
21. Mori M, Mimori K, Shiraishi T, Tanaka S, Ueo H, Sugimachi K, Akiyoshi T: p27 expression and gastric carcinoma. Nature Med 3:593, 1997
22. Bartkova J, Lukas J, Strauss M, Bartek J: Cyclin D1 oncoprotein aberrantly accumulates in malignancies of diverse histogenesis. Oncogene 10:775-778, 1995
23. Jiang W, Kahn SM, Tomita N, Zhong YJ, Lu SH, Weinstein B: Amplification and expression of the human cyclin D gene in esophageal cancer. Cancer Res 52:2980-2983, 1992
24. Gillet C, Frantl V, Smith R, Fisher C, Bartek J, Dickson C, Barnes D, Peters G: Amplification and overexpression of cyclin D1 in breast cancer detected by immunohistochemical staining. Cancer Res 54:1812-1817, 1994
25. Kallakury BVS, Sheehan CE, Ambros RA, Fish HAG, Kaufman RP, Ross JS: The prognostic significance of p34cdc2 and cyclin D1 protein expression in prostate adenocarcinoma. Cancer 80:753-763, 1997
26. van Diest PJ, Michalides RJAM, Jannink IIse, Valk PVD, Peterse Hl, de Jong JS, Meijer CJLM, Baak JPA: Cyclin D1 expression in invasive breast cancer. Am J Pathol 150:705-711, 1997
27. Bartkova J, Lukas J, Muller H, Lutzhoft D, Strauss M, Bartek J: Cycin D1 protein expression and function in human breast cancer. Int J Cancer 57:353-361, 1994
28. Wang TC, Cardiff RD, Zukerberg L, Lees E, Arnold A, Schmidt EV: Mammary hyperplasia and carcinoma in MMTV-cyclin D1 transgenic mice. Nature 369:669-671, 1994
29. Worsley SD, Ponder BAJ, Davies BR: Overexpression of cyclin D1 in epithelial ovarian cancers. Gynecol Oncol 64:189-195, 1997
30. Courjal F, Louason G, Speiser P, Katsarose D, Zeillinger R, Theillet C: Cyclin gene amplification and overexpression in breast and ovarian cancers: evidence for the selection of cyclin D1 in breast and cyclin E in ovarian tumors. Int J Cancer 69:247-253, 1996
31. Teneriello MG, Ebina M, Linnoila RI, Henry M, Nash JD, Park RC, Birrer MJ: p53 and Ki-ras gene mutations in epithelial ovarian neoplasms. Cancer Res 53:3103-3108, 1993
32. Han EK, Begeann M, Sagambato A, Soh JW, Doki Y, Xing WQ, Liu W, Weinstein IB: Increased expression of cyclin D1 in a murine mammary epithelial cell line induces p27kip1, inhibits growth, and enhances apoptosis. Cell Growth Differ 7:699-710, 1996
33. Porter PL, Malone KE, Heagerty PJ, Alexander GM, Gatti LA, Firpo EJ, Daling JR, Roberts JM: Expression of cell-cycle regulators p27kip1 and cyclin E, alone and in combination, correlate with survival in young breast cancer patients. Nature Med 3:222-225, 1997
34. kip1. Genes Dev 11:1464-1478, 1997
35. Sherr CJ: Cancer cell-cycles. Science 274:1672-1677, 1996
36. 1-to-S transition. Mol Cell Biol 15:3463-3469, 1995